» Articles » PMID: 36398243

Cytokine Profiling in Patients with Polypoidal Choroidal Vasculopathy Before and After Intravitreal Injection of Ranibizumab

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2022 Nov 18
PMID 36398243
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to investigate the cytokines profiling in the aqueous humor of patients with polypoidal choroidal vasculopathy (PCV) before and after intravitreal ranibizumab injection (IVR).

Methods: 14 patients clinically diagnosed with PCV and 15 cataract patients of similar age and gender (control group) were included. Throughout the cataract surgery and IVR, aqueous humor samples were collected from the PCV and control groups.

Results: The levels of macrophage inflammatory protein 1β (MIP-1β) and normal T cell expressed and secreted (RANTES) in PCV patients were significantly lower than control subjects (P=0.045 and P=0.004, respectively). The concentration of vascular endothelial growth factor-A (VEGF-A) was significantly higher than the control group (P=0.003). The level of MIP-1β was greatly increased in PCV patients compared to prior to IVR (P=0.001). After IVR, the level of VEGF-A in PCV patients were considerably lower compared to before IVR (P=0.001). There was no link between the expression of several cytokines (MCP-1, MIP-1, Eotaxin, G-CSF, IL-8, IL-6, IL-5, IP-10 and IFN-γ) in the aqueous humor of PCV patients before and after intravitreal ranibizumab injection (IVR). The association between IL-5 expression and central macular thickness (CMT) was discovered before IVR (P=0.02), however, the correlation between several cytokines (MCP-1, MIP-1, Eotaxin, G-CSF, IL-8, IL-6, IL-5, IP-10 and IFN-γ) was discovered in PCV patients after IVR.

Conclusion: Based on our findings, we discovered that the production of neovascularization in PCV patients is driven by both angiogenic and inflammatory factors, with a correlation seen between several cytokines.

References
1.
Deshauer C, Morgan A, Ryan E, Handel T, Prestegard J, Wang X . Interactions of the Chemokine CCL5/RANTES with Medium-Sized Chondroitin Sulfate Ligands. Structure. 2015; 23(6):1066-77. PMC: 4456249. DOI: 10.1016/j.str.2015.03.024. View

2.
Barcelos L, Coelho A, Russo R, Guabiraba R, Souza A, Bruno-Lima Jr G . Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc Res. 2009; 78(2):148-54. DOI: 10.1016/j.mvr.2009.04.009. View

3.
Honczarenko M, Le Y, Glodek A, Majka M, Campbell J, Ratajczak M . CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood. 2002; 100(7):2321-9. DOI: 10.1182/blood-2002-01-0248. View

4.
Miyata M, Ooto S, Yamashiro K, Tamura H, Hata M, Ueda-Arakawa N . Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2018; 103(5):617-622. DOI: 10.1136/bjophthalmol-2018-311963. View

5.
Yannuzzi L, Sorenson J, Spaide R, Lipson B . Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990; 10(1):1-8. View